Richmond Pharmacology welcomes you to attend the ACCP 40th Annual Meeting, taking place 11th to 13th Sept, 2011

Posted:
9
September 2011

Richmond Pharmacology welcomes you to attend the ACCP 40th Annual Meeting, taking place 11th to 13th Sept, 2011 at the Crowne Plaza Chicago O'Hare Hotel. This years meeting promises to be an exciting event that will hosting a series of excellent workshops and symposia on current, relevant topics related to improving the optimal development and use of therapeutics, with a specific focus on clinical pharmacology.Richmond Pharmacologys CEO and co-founder Dr Jorg Taubel is due to present on Monday 12th September from 18h00 to 20h00, covering the following topics of discussion:

  • Alternative Methods for The Confirmation Of Assay Sensitivity In Thorough QT Studies
  • The Use of Non-invasive Blood Pressure Recording By Photoplethysmography In Early Phase Clinical Trial Studies

Furthermore, Richmond Pharmacology will be exhibiting at the meeting, if you plan to attend we welcome you to come see us at booth number 3 to learn more about our service offering and how our specialist expertise can enhance your next clinical study. If you would like to arrange a face to face meeting with Dr Taubel, please contact a member of our business development team to arrange a time at your convenience.

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more